Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886744-21-000039
Filing Date
2021-05-13
Accepted
2021-05-13 21:23:52
Documents
1
Period of Report
2021-05-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4035
  Complete submission text file 0000886744-21-000039.txt   5537
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REATA PHARMACEUTICALS, INC. 2801 GATEWAY DRIVE, SUITE 150 IRVING TX 75063
Business Address
Bir Dawn Carter (Reporting) CIK: 0001688712 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20859 | Film No.: 21921670